pInducer20_SLC38A2_N82A
(Plasmid
#156183)
-
PurposeDox-inducible expression of sgRNA-resistant SLC38A2 N82A mutant cDNA.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 156183 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepInducer20
- Backbone size w/o insert (bp) 11000
- Total vector size (bp) 11669
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSLC38A2
-
Alt nameSNAT2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1521
-
MutationSilent mutations to prevent targeting by sgRNA: TAATCTGAGCAATGCGATTG. N82A (AAT --> GCT) "transport defective" mutation.
-
Entrez GeneSLC38A2 (a.k.a. ATA2, PRO1068, SAT2, SNAT2)
- Promoter TRE
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer LNCX (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pInducer20_SLC38A2_N82A was a gift from Alec Kimmelman (Addgene plasmid # 156183 ; http://n2t.net/addgene:156183 ; RRID:Addgene_156183) -
For your References section:
Selective alanine transporter utilization creates a targetable metabolic niche in pancreatic cancer. Parker SJ, Amendola CR, Hollinshead KER, Yu Q, Yamamoto K, Encarnacion-Rosado J, Rose RE, LaRue MM, Sohn ASW, Biancur DE, Paulo JA, Gygi SP, Jones DR, Wang H, Philips MR, Bar-Sagi D, Mancias JD, Kimmelman AC. Cancer Discov. 2020 Apr 27. pii: 2159-8290.CD-19-0959. doi: 10.1158/2159-8290.CD-19-0959. 10.1158/2159-8290.CD-19-0959 PubMed 32341021